These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4321503)

  • 1. Cushing's syndrome caused by malignant tumor in the scrotum: clinical, pathologic and biochemical studies.
    Morimoto Y; Hiwada K; Nanahoshi M; Yano S; Kumagai A; Yamamura Y; Koto K; Uda H; Okano K; Yamane G
    J Clin Endocrinol Metab; 1971 Feb; 32(2):201-10. PubMed ID: 4321503
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 3. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cushing's syndrome caused by a malignant thymus tumor secreting corticotropin].
    Barthelme J; Kesseler A; Romani JD; Renault P; Phan Huu Trung ; Albeaux-Fernet M
    Ann Endocrinol (Paris); 1968; 29(2):263-8. PubMed ID: 4298420
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroidal and gonadotropin evaluation of a patient with a feminizing tumor of the adrenal gland. In vivo and in vitro studies.
    Rose LI; Williams GH; Emerson K; Villee DB
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1526-32. PubMed ID: 4242282
    [No Abstract]   [Full Text] [Related]  

  • 6. Medullary carcinoma of the thyroid--a cause of Cushing's syndrome: report of two cases.
    Donahower GF; Schumacher OP; Hazard JB
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1199-204. PubMed ID: 4300147
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome.
    Sparks LL; Smilo RP; Pavlatos FC; Forsham PH
    Metabolism; 1969 Mar; 18(3):175-92. PubMed ID: 4304881
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation of Cushing's syndrome during pregnancy: report of a case.
    Calodney L; Eaton RP; Black W; Cohn F
    J Clin Endocrinol Metab; 1973 Jan; 36(1):81-6. PubMed ID: 4344310
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent Cushing's disease following "total" adrenalectomy.
    Siegal AM; Kreisberg RA; Hershman JM; Owen WC
    Arch Intern Med; 1972 Apr; 129(4):642-7. PubMed ID: 4336309
    [No Abstract]   [Full Text] [Related]  

  • 10. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome in association with a carcinoid tumor of the lung.
    Steel K; Baerg RD; Adams DO
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1285-9. PubMed ID: 4292249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 13. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 14. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
    Liberman B; Wajchenberg BL; Tambascia MA; Mesquita CH
    J Clin Endocrinol Metab; 1976 Oct; 43(4):913-8. PubMed ID: 185234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant tumor of the thymus and Cushing's syndrome].
    Albeaux-Fernet M; Romani JD; Kesseler A; Barthelme J
    Presse Med (1893); 1968 Feb; 76(9):415-8. PubMed ID: 4295995
    [No Abstract]   [Full Text] [Related]  

  • 16. Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
    Pennington LF; Kreisberg RA; Hershman JM
    J Clin Endocrinol Metab; 1970 Jan; 30(1):125-7. PubMed ID: 4311614
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of cortisol in Cushing's syndrome.
    Ghosh PC; Pennington GW
    Steroids; 1969 Sep; 14(3):369-80. PubMed ID: 5821993
    [No Abstract]   [Full Text] [Related]  

  • 18. A new male pseudo-hermaphroditism associated with hypertension due to a block of 17 -hydroxylation.
    Bricaire H; Luton JP; Laudat P; Legrand JC; Turpin G; Corvol P; Lemmer M
    J Clin Endocrinol Metab; 1972 Jul; 35(1):67-72. PubMed ID: 5032516
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's syndrome: adrenocortical hyperactivity secondary to neoplasms arising outside the pituitary-adrenal system.
    Friedman M; Marshall-Jones P; Ross EJ
    Q J Med; 1966 Apr; 35(138):193-214. PubMed ID: 4287900
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia.
    New MI; Seaman MP
    J Clin Endocrinol Metab; 1970 Mar; 30(3):361-71. PubMed ID: 4312795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.